Understanding LHPP: Potential Drug Target and Biomarker (G64077)

Target Name: LHPP

NCBI ID: G64077

LHPP

Understanding LHPP: Potential Drug Target and Biomarker

LHPP (LHPP_HUMAN), also known as human long-chain plasma protein, is a protein that is produced by the human body and has been shown to have a number of potential drug targets and biological functions.

The LHPP protein is a member of the plasma protein family, which is a group of proteins that are produced by the liver and other tissues and are responsible for a variety of functions, including maintaining the osmotic pressure of the blood and participating in the immune response.

One of the key functions of the LHPP protein is its role in maintaining the stability of the blood. Plasma proteins, including LHPP, help to keep the blood from clotting and prevent blood from thickening, which is important for maintaining proper circulation and oxygenation of the body's tissues.

In addition to its role in maintaining the blood, LHPP has also been shown to play a number of other important roles in the body. For example, it has been shown to help regulate the immune response, protect against infection and disease, and participate in the formation of new blood vessels.

Given its many important functions, LHPP has been identified as a potential drug target. Researchers are currently working to develop new treatments and therapies that target LHPP and are investigating the potential benefits and risks of these treatments.

One of the main challenges in developing new treatments for LHPP is the fact that the protein is produced by the body and has a complex structure that is difficult to alter. This makes it difficult to develop drugs that specifically target LHPP and can cause unintended side effects.

Despite these challenges, researchers are making progress in the development of new treatments for LHPP. For example, researchers have developed a number of compounds that are specifically designed to target LHPP and have shown that these compounds can be effective in animal models of disease.

In addition to developing new treatments, researchers are also working to identify new biomarkers for LHPP. By studying the levels and activity of LHPP, researchers can gain a better understanding of how the protein functions in the body and identify potential targets for new therapies.

Overall, LHPP is a protein that has the potential to be a valuable drug target and biomarker. With further research and development, researchers hope to be able to create new treatments and therapies that can help to improve the health and well-being of people with a variety of conditions.

Protein Name: Phospholysine Phosphohistidine Inorganic Pyrophosphate Phosphatase

Functions: Phosphatase that hydrolyzes imidodiphosphate, 3-phosphohistidine and 6-phospholysine. Has broad substrate specificity and can also hydrolyze inorganic diphosphate, but with lower efficiency (By similarity)

The "LHPP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LHPP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets